| 0.35 -0.252 (-41.87%) | 06-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.69 |
1-year : | 0.87 |
| Resists | First : | 0.59 |
Second : | 0.74 |
| Pivot price | 0.6 |
|||
| Supports | First : | 0.34 |
Second : | 0.29 |
| MAs | MA(5) : | 0.55 |
MA(20) : | 0.63 |
| MA(100) : | 0.75 |
MA(250) : | 0.98 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 10.6 |
D(3) : | 17.4 |
| RSI | RSI(14): 14.7 |
|||
| 52-week | High : | 2.48 | Low : | 0.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TNON ] has closed below the lower bollinger band by 37.8%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 63.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.61 - 0.61 | 0.61 - 0.62 |
| Low: | 0.59 - 0.6 | 0.6 - 0.6 |
| Close: | 0.6 - 0.6 | 0.6 - 0.61 |
Tenon Medical, Inc. is a medical device firm dedicated to developing advanced surgical implant solutions. These systems are designed to enhance sacroiliac joint (SIJ) fixation and fusion operations, ultimately leading to better patient outcomes. The company markets The CATAMARAN SIJ Fusion System, which includes both specialized instruments and implants, specifically engineered for the preparation and secure fusion of the SI-Joint. This product is distributed throughout the United States and Puerto Rico. Founded in 2012, Tenon Medical's operations are headquartered in Los Gatos, California.
Wed, 17 Jun 2026
Tenon Medical Inc (TNON) Institutional Confidence - TradingKey
Wed, 17 Jun 2026
Tenon Medical Inc (TNON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fri, 12 Jun 2026
Executive pay rises and chairman contract extended at Tenon Medical (TNON) - Stock Titan
Fri, 12 Jun 2026
Tenon Medical (NASDAQ: TNON) proposes reverse split, ratifies March 11 debt issuance - Stock Titan
Thu, 11 Jun 2026
Tenon Medical (TNON) lowers quorum threshold and updates voting rules - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 12 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 13.7 (%) |
| Held by Institutions | 3.1 (%) |
| Shares Short | 149 (K) |
| Shares Short P.Month | 193 (K) |
| EPS | -1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.11 |
| Profit Margin | -270.1 % |
| Operating Margin | -237.9 % |
| Return on Assets (ttm) | -55.4 % |
| Return on Equity (ttm) | -220.4 % |
| Qtrly Rev. Growth | 89.9 % |
| Gross Profit (p.s.) | 0.25 |
| Sales Per Share | 0.39 |
| EBITDA (p.s.) | -0.99 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.35 |
| PEG Ratio | 0 |
| Price to Book value | -3.5 |
| Price to Sales | 0.88 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|